The nation of Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) over five years due to Washington's demand for sensitive information.
The decision became public following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman later clarified that the United States was requesting biological samples for research and profit but was unwilling to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further dialogue to reach a deal acceptable to both sides so the nation's vital HIV programme can continue.
Wider Background
Zimbabwe's decision comes after a similar case in Kenya, where a court suspended a similar health funding agreement following legal challenges were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on reports, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures previously set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how subsequent co-operation might be arranged in a way that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks should continue given that a large portion of the country's Aids initiatives depended on international support.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it commented.
This impasse highlights the ongoing tensions between accepting vital foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.